EPCAM and cancer: Conversely, the high-risk group exhibited significantly higher fractions of Ki-67+/PanCK+ and CD44+/EpCAM+ tiles, reflecting a proliferative tumor and cancer stem cell niche (P < 0.001 for all comparisons; Fig. 5d).